Hydrogen peroxide induces the death astrocytes through the down-regulation of the constitutive nuclear factor-kappaB activity

Free Radical Research

Volumn 41, Issue 5, 2007, Pages 555-562

  Choi, Jung Jin ^a   Choi, JiWoong ^a,b   Kang, Chi Dug ^c   Chen, Xia ^a,d   Wu, Chun Fu ^d   Ko, Kwang Ho ^b   Kim, Won Ki ^a  

^a Ewha Womans University   (South Korea)

^b Seoul National University   (South Korea)

^c Pusan National University   (South Korea)

^d SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Astrocyte; H2O2; LDH release; NF BB

Indexed keywords

DNA; HYDROGEN PEROXIDE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; PROTEIN SUBUNIT; SYNAPTOTAGMIN I; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; ASTROCYTES; CELL DEATH; CELLS, CULTURED; DOWN-REGULATION; HYDROGEN PEROXIDE; NF-KAPPA B; OXIDANTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34047180590     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760601173010     Document Type: Article

References (42)

1. Cui, K., Luo, X. and Murthy, Ven MR (2004) Role of oxidative stress in neurodegeneration: Recent development in assay methods for oxidative stress and nutraceutical antioxidants. Prog Neuropsychopharmacol Biol Psychiatry, 28, pp. 771-799.
2. 2 in vitro. Brain Res, 671, pp. 181-186.
3. Tabner, BJ, Turnbull, S., El-Agnaf, OM and Allsop, D. (2002) Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Radic Biol Med, 32, pp. 1076-1083.
4. Dringen, R., Kussmaul, L., Gutterer, JM, Hirrlinger, J. and Hamprecht, B. (1999) The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J Neurochem, 72, pp. 2523-2530.
5. Vexler, ZS, Wong, A., Francisco, C., Manabat, C., Christen, S., Tüuber, M., Ferriero, DM and Gregory, G. (2003) Fructose-1,6-bisphosphate preserves intracellular glutathione and protects cortical neurons against oxidative stress. Brain Res, 960, pp. 90-98.
6. Desagher, S., Glowinski, J. and Premont, J. (1996) Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci, 16, pp. 2553-2562.
7. Yoon, KN, Oh, YK, Kim, HC, Shin, CY, Ryu, JR, Ko, KH and Kim, WK (2000) Synergistic depletion of astrocytic glutathione by glucose deprivation and peroxynitrite: Correlation with mitochondrial dysfunction and subsequent cell death. J Neurochem, 74, pp. 1989-1998.
8. Papadopoulos, MC, Koumenis, IL, Yuan, TY and Giffard, RG (1998) Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses. Neuroscience, 82, pp. 915-925.
9. Juknat, AA, Valle, M del, Méndez, A., Quaglino, A., Fameli, CI, Mena, M. and Kotler, ML (2005) Melatonin prevents hydrogen peroxide-induced Bax expression in cultured rat astrocytes. J Pineal Res, 38, pp. 84-92.
10. May, MJ and Ghosh, S. (1998) Signal transduction through NF-κB. Immunol Today, 19, pp. 80-88.
11. Mattson, MP, Culmsee, C. and Camandola, S. (2000) Roles of nuclear factor κB in neuronal survival and plasticity. J Neurochem, 74, pp. 443-456.
12. Nurmi, A., Lindsberg, PJ, Koistinaho, M., Zhang, W., Juettler, E., Karjalainen-Lindsberg, ML, Weih, F., Frank, N., Schwaninger, M. and Koistinaho, J. (2004) Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke, 35, pp. 987-991.
13. Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, LF, Kwon, H., Mucke, L. and Gan, L. (2005) SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem, 280, pp. 40364-40374.
14. Zhang, W., Potrovita, I., Tarabin, V., Herrmann, O., Beer, V., Weih, F., Schneider, A. and Schwaninger, M. (2005) Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab, 25, pp. 30-40.
15. Fridmacher, V., Kaltschmidt, B., Goudeau, B., Ndiaye, D., Rossi, FM, Pfeiffer, J., Kaltschmidt, C., Israël, A. and Mémet, S. (2003) Forebrain-specific neuronal inhibition of nuclear factor-κB activity leads to loss of neuroprotection. J Neurosci, 23, pp. 9403-9408.
16. Jang, JH and Surh, YJ (2004) Bcl-2 attenuation of oxidative cell death is associated with up-regulation of γ-glutamylcysteine ligase via constitutive NF-κB activation. J Biol Chem, 279, pp. 38779-38786.
17. Takada, Y., Singh, S. and Aggarwal, BB (2004) Identification of a p65 peptide that selectively inhibits NF-κB activation induced by various inflammatory stimuli and its role in down-regulation of NF-κB-mediated gene expression and up-regulation of apoptosis. J Biol Chem, 279, pp. 15096-15104.
18. Erl, W., Hansson, GK, de Martin, R., Draude, G., Weber, KSC and Weber, C. (1999) Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res, 84, pp. 668-677.
19. 2+. Am J Physiol Cell Physiol, 278, pp. C1116-C1125.
20. Bales, KR, Dodel, RC, Yan, GM, Hamilton-Byrd, E. and Paul, SM (1998) The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Brain Res Mol Brain Res, 57, pp. 63-72.
21. Lezoualc'h, F., Sagara, Y., Holsboer, F. and Behl, C. (1998) High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells. J Neurosci, 18, pp. 3224-3232.
22. Woo, MS, Jung, SH, Kim, SY, Hyun, JW, Ko, KH, Kim, W-K and Kim, HS (2005) Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun, 335, pp. 1017-1025.
23. Schouten, GJ, Vertegaal, AC, Whiteside, ST, Israel, A., Toebes, M., Dorsman, JC, van der Eb, AJ and Zantema, A. (1997) IkappaB alpha is a target for the mitogen-activated 90 κDa ribosomal S6 kinase. EMBO J, 16, pp. 3133-3144.
24. Snyder, JG, Prewitt, R., Campsen, J. and Britt, LD (2002) PDTC and MG132, inhibitors of NF-kappaB, block endotoxin induced vasodilation of isolated rat skeletal muscle arterioles. Shock, 17, pp. 304-307.
25. Robb, SJ and Connor, JR (1998) An in vitro model for analysis of oxidative death in primary mouse astrocytes. Brain Res, 788, pp. 125-132.
26. Almeida, A., Almeida, J., Bolanos, JP and Moncada, S. (2001) Different responses of astrocytes and neurons to nitric oxide: The role of glycolytically generated ATP in astrocytes protection. Proc Natl Acad Sci USA, 98, pp. 15294-15299.
27. Gorina, R., Petegnief, V., Chamorro, A. and Planas, AM (2005) AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: Involvement of the Jak2/STAT pathway. J Neurochem, 92, pp. 505-518.
28. Kim, EJ, Park, YG, Baik, EJ, Jung, SJ, Won, R., Nahm, TS and Lee, BH (2005) Dehydroascorbic acid prevents oxidative cell death through a glutathione pathway in primary astrocytes. J Neurosci Res, 79, pp. 670-679.
29. Shinozaki, Y., Koizumi, S., Ohno, Y., Nagao, T. and Inoue, K. (2006) Extracellular ATP counteracts the ERK1/2-mediated death-promoting signaling cascades in astrocytes. Glia, 54, pp. 606-618.
30. Karin, M. (2000) Signaling pathways leading to nuclear factor-kappa B activation. Methods Enzymol, 319, pp. 273-279.
31. Bowie, A. and O'Neill, AJ (2000) Oxidative stress and nuclear factor-κB activation. A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol, 59, pp. 13-23.
32. Takada, Y. and Aggarwal, BB (2004) Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: Abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J Biol Chem, 279, pp. 4750-4759.
33. Schreck, R., Rieber, P. and Baeuerle, PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J, 10, pp. 2247-2258.
34. Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, PA and Kaltschmidt, C. (1997) Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA, 94, pp. 2642-2647.
35. Byun, MS, Jeon, KI, Choi, JW, Shim, JY and Jue, DM (2002) Dual effect of oxidative stress on NF-κB activation in HeLa cells. Exp Mol Med, 34, pp. 332-339.
36. Kaltschmidt, B., Kaltschmidt, C., Hofmann, TG, Hehner, SP, Dröge, W. and Schmitz, ML (2000) The pro- or anti-apoptotic function of NF-κB is determined by the nature of the apoptotic stimulus. Eur J Biochem, 267, pp. 3828-3835.
37. Kim, DK, Cho, ES, Lee, BR and Um, HD (2001) NF-kappa B mediates the adaptation of human U937 cells to hydrogen peroxide. Free Radic Biol Med, 30, pp. 563-571.
38. Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B. and Kaltschmidt, C. (1999) Inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosis. Proc Natl Acad Sci USA, 96, pp. 9409-9414.
39. Giri, DK and Aggarwal, BB (1998) Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem, 273, pp. 14008-14014.
40. Poulaki, V., Mitsiades, CS, Joussen, AM, Lappas, A., Kirchhof, B. and Mitsiades, N. (2002) Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability. Am J Pathol, 161, pp. 2229-2240.
41. Bian, X., Opipari Jr., AW, Ratanaproeksa, AB, Boitano, AE, Lucas, PC and Castle, VP (2002) Constitutively active NFkappa B is required for the survival of S-type neuroblastoma. J Biol Chem, 277, pp. 42144-42150.
42. Lim, JH, Lee, JC, Lee, YH, Choi, IY, Oh, YK, Kim, HS, Park, JS and Kim, WK (2006) Simvastatin prevents oxygen and glucose deprivation/ reoxygenation-induced death of cortical neurons by reducing the production and toxicity of 4-hydroxy-2E-nonenal. J Neurochem., 97, pp. 140-150.